YahooSeptember 20, 2026 at 8:50 AM NYLast Month
Wall Street's Bull Case for Bristol Myers Squibb Is Getting Louder
The company's strong pipeline and newer approved drugs should be enough to allay patent expiration concerns.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
